The mRNA-based BNT162b2 vaccine from Pfizer/BioNTech was the first registered COVID-19 vaccine and has been shown to be up to 95% effective in preventing SARS-CoV-2 infections. Little is known about t
The mRNA SARS-CoV-2 vaccines were brought to market in response to the public health crises of Covid-19. The utilization of mRNA vaccines in the conte…
非營利的FactCheck（事實查核）2022-7-29發表COVID-19 Vaccination Increases Immu
The mRNA COVID-19 vaccines teach the immune system to recognize and fight the coronavirus, greatly reducing the likelihood of severe disease if a person is infected. There is no evidence the vaccines
The content above by Cofacts message reporting chatbot and crowd-sourced fact-checking community is licensed under Creative Commons Attribution-ShareAlike 4.0 (CC BY-SA 4.0), the community name and the provenance link for each item shall be fully cited for further reproduction or redistribution.
